company background image
PRHB

Pure H20 Bio-Technologies OTCPK:PRHB Stock Report

Last Price

US$0.000001

Market Cap

US$1.5k

7D

0%

1Y

n/a

Updated

12 Oct, 2024

Data

Company Financials

Pure H20 Bio-Technologies, Inc.

OTCPK:PRHB Stock Report

Market Cap: US$1.5k

PRHB Stock Overview

No business description. More details

PRHB fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health0/6
Dividends0/6

My Notes

Capture your thoughts, links and company narrative

Pure H20 Bio-Technologies, Inc. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Pure H20 Bio-Technologies
Historical stock prices
Current Share PriceUS$0.000001
52 Week HighUS$0.0001
52 Week LowUS$0.000001
Beta0
1 Month Change0%
3 Month Changen/a
1 Year Changen/a
3 Year Change-99.00%
5 Year Change0%
Change since IPO-100.00%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

PRHBUS Consumer DurablesUS Market
7D0%-4.7%-0.3%
1Yn/a4.7%20.4%

Return vs Industry: Insufficient data to determine how PRHB performed against the US Consumer Durables industry.

Return vs Market: Insufficient data to determine how PRHB performed against the US Market.

Price Volatility

Is PRHB's price volatile compared to industry and market?
PRHB volatility
PRHB Average Weekly Movementn/a
Consumer Durables Industry Average Movement6.0%
Market Average Movement6.0%
10% most volatile stocks in US Market18.5%
10% least volatile stocks in US Market3.0%

Stable Share Price: PRHB's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: Insufficient data to determine PRHB's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
n/an/an/an/a

Pure H20 Bio-Technologies, Inc. Fundamentals Summary

How do Pure H20 Bio-Technologies's earnings and revenue compare to its market cap?
PRHB fundamental statistics
Market capUS$1.50k
Earnings (TTM)US$0
Revenue (TTM)n/a

n/a

P/E Ratio

n/a

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
PRHB income statement (TTM)
RevenueUS$0
Cost of RevenueUS$0
Gross ProfitUS$0
Other ExpensesUS$0
EarningsUS$0

Last Reported Earnings

n/a

Next Earnings Date

n/a

Earnings per share (EPS)0
Gross Margin0.00%
Net Profit Margin0.00%
Debt/Equity Ratio0.0%

How did PRHB perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/10/12 07:48
End of Day Share Price 2024/07/15 00:00
EarningsN/A
Annual EarningsN/A

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Pure H20 Bio-Technologies, Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.